| PknB remains an essential and a conserved target for drug development in susceptible and MDR strains of M. Tuberculosis A Gupta, SK Pal, D Pandey, NA Fakir, S Rathod, D Sinha, S SivaKumar, ... Annals of clinical microbiology and antimicrobials 16, 1-10, 2017 | 15 | 2017 |
| Exploration of freely available web-interfaces for comparative homology modelling of microbial proteins V Nema, SK Pal Bioinformation 9 (15), 796, 2013 | 12 | 2013 |
| Elucidation of Antiviral and Antioxidant Potential of C-Phycocyanin against HIV-1 Infection through In Silico and In Vitro Approaches P Jadaun, C Seniya, SK Pal, S Kumar, P Kumar, V Nema, SS Kulkarni, ... Antioxidants 11 (10), 1942, 2022 | 9 | 2022 |
| LpxC (UDP-3-O-(R-3-hydroxymyristoyl)-N-acetylglucosamine deacetylase) inhibitors: A long path explored for potent drug design SK Pal, S Kumar International Journal of Biological Macromolecules 234, 122960, 2023 | 5 | 2023 |
| Prospecting potential inhibitors of Sortase a from Enterococcus faecalis: A multidrug resistant bacteria, through in-silico and in-vitro approaches S Das, V Kumar HS, SK Pal, VK Srivastava, A Jyoti, S Kumar, S Kaushik Protein and Peptide Letters 27 (7), 582-592, 2020 | 4 | 2020 |
| Synthesis and Biological Evaluation of a Series of Quinoline‐Based Quinazolinones and Carbamic Anhydride Derivatives M Reddy Manne, RR Panicker, K Ramakrishnan, HMK Hareendran, ... ChemistrySelect 8 (3), e202204508, 2023 | 3 | 2023 |
| Purification, Biochemical Characterization, and DPP‐IV and α‐amylase inhibitory activity of Berberine from Cardiospermum halicacabum S Naik, N Deora, SK Pal, MZ Ahmed, AS Alqahtani, PK Shukla, ... Journal of Molecular Recognition, e2983, 2022 | 3 | 2022 |
| Exploring the molecular interaction of Pheniramine with Enterococcus faecalis Homoserine Kinase: In‐silico and in vitro studies J Yadav, H Singh, SK Pal, S Das, VK Srivastava, A Jyoti, V Sharma, ... Journal of Molecular Recognition, e2979, 2022 | 1 | 2022 |
| Indole-based LpxC (UDP-3-O-(R-3-hydroxyacyl)-N-acetylglucosaminedeacetylase) inhibitors for Salmonella typhi: rational drug discovery through in silico screening S Kumar Pal, S Kumar 3 Biotech 13 (8), 281, 2023 | | 2023 |
| The in-silico hunt for the inhibitor against LpxC enzyme from Salmonella Typhi from natural product derivatives sudhir kumar pal, tarun kumar International Journal of Innovation and Multidisciplinary Research 3 (2), 2023 | | 2023 |
| Molecular Mechanisms of Antimicrobial Resistance and New Targets to Address Current Drug Resistance D Karthikeyan, SK Pal, M Kumar, K Kishore, R Tetala, P Kaur, S Kumar Current Developments in the Detection and Control of Multi Drug Resistance, 89, 2022 | | 2022 |
| Structural and functional studies of key enzyme (LpxC (UDP-3-O-acyl-N-acetylglucosamine deacetylase) from salmonella typhi involved in Gram-negative bacterial lipid A biosynthesis SK Pal, S Kumar Acta Crystallographica Section A: Foundations and Advances 77, C927-C927, 2021 | | 2021 |
| Structural Comparison of Wild and Mutated Matrix Protein of Nipah Virus via in-silico Approach S kumar Pal British Biotechnology Journal 3 (4), 545, 2013 | | 2013 |
| prion protein in the influence of alzheimer's disease sudhir kumar pal journal of advanced bioinformatics applications and research 3 (2), 317-323, 2012 | | 2012 |
| COMPARATIVE MODELLING OF EMBB PROTEIN OF Mycobacterium tuberculosis AND STRUCTURE REFINEMENT LR Samant, SK Pal, U Bhele | | 2012 |
Vijay NemaNational AIDS Research InstituteVerified email at nariindia.org
